-
公开(公告)号:US11185561B2
公开(公告)日:2021-11-30
申请号:US15881302
申请日:2018-01-26
Inventor: Yukihiro Ohya , Shigenori Kabashima , Osamu Natsume , Hirohisa Saito
Abstract: The present invention provides an egg allergy prevention method to be carried out with respect to a human infant, including: a first administration period (first administration step) in which to administer, to an infant, heated egg white protein in an amount of 10 mg to 20 mg per day; and a second administration period (second administration step) which is a period after the first administration period and in which to administer, to the infant, the heated egg white protein in an amount of 65 mg to 90 mg per day.
-
公开(公告)号:US11827719B2
公开(公告)日:2023-11-28
申请号:US16841527
申请日:2020-04-06
Inventor: Hirohisa Saito , Kenji Matsumoto , Hideaki Morita , Go Ichien , Yasuhiko Koezuka , Kimishige Ishizaka
CPC classification number: C07K16/4291 , A61P37/08
Abstract: The disclosure provides a pharmaceutical composition containing an anti-IgE antibody that suppresses the production of allergen-specific IgE antibodies and methods of use thereof.
-
3.
公开(公告)号:US20200231705A1
公开(公告)日:2020-07-23
申请号:US16841527
申请日:2020-04-06
Inventor: Hirohisa Saito , Kenji Matsumoto , Hideaki Morita , Go Ichien , Yasuhiko Koezuka , Kimishige Ishizaka
Abstract: The disclosure provides a pharmaceutical composition containing an anti-IgE antibody that suppresses the production of allergen-specific IgE antibodies and methods of use thereof
-
-